Keyphrases
COVID-19
100%
Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
100%
Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
100%
Pathogenic Response
100%
Pulmonary Fibrosis
42%
Coronavirus
42%
Acute Respiratory Distress Syndrome
42%
Potential Treatments
28%
Therapeutic Approaches
28%
Host Immune Response
28%
Immune Response
28%
Coronavirus Infections
28%
Prevention Strategies
14%
Clinical Trials
14%
Molecular Mechanism
14%
Vaccine Development
14%
Putting
14%
World Economy
14%
Immune Cells
14%
Taking Care
14%
Health Systems
14%
Combined Treatment
14%
Infected Patients
14%
Invasion Pathways
14%
Infection Process
14%
Virus Invasion
14%
Major Complications
14%
Immune Therapy
14%
Viral Structure
14%
Wuhan China
14%
Global Pandemic
14%
Inflammatory Immune Response
14%
Medication Cost
14%
Severe Cases
14%
Severe Respiratory Failure
14%
Cytokine Storm
14%
Lymphopenia
14%
Global Health Care
14%
Direct Killing
14%
Immune Effect
14%
Novel Coronavirus
14%
Novel Coronavirus SARS-CoV-2
14%
MERS-CoV Infection
14%
Clinical Resolution
14%
Medicine and Dentistry
Infection
100%
Severe Acute Respiratory Syndrome
100%
Immunity
100%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
SARS Coronavirus
100%
Middle East Respiratory Syndrome Coronavirus
100%
Immune Response
66%
Acute Respiratory Distress Syndrome
50%
Pulmonary Fibrosis
50%
Coronavirus
50%
Coronavirinae
33%
Coronavirus Infection
33%
Immunotherapy
16%
Health Care Cost
16%
Clinical Trial
16%
Serositis
16%
Immunocompetent Cell
16%
COVID-19
16%
Cytokine Storm
16%
Lymphocytopenia
16%
Vaccine Development
16%
Virus Morphology
16%
Diseases
16%
Immunology and Microbiology
Immunity
100%
Severe Acute Respiratory Syndrome
100%
SARS Coronavirus
100%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Middle East Respiratory Syndrome Coronavirus
100%
Coronavirinae
66%
Coronavirus
50%
Immune Response
33%
Host Immune Response
33%
Immunotherapy
16%
Immunocompetent Cell
16%
Inflammation Response
16%
COVID-19
16%
Cytokine Storm
16%
Lymphocytopenia
16%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
100%
Severe Acute Respiratory Syndrome
100%
SARS Coronavirus
100%
Middle East Respiratory Syndrome Coronavirus
100%
Lung Fibrosis
33%
Adult Respiratory Distress Syndrome
33%
Syndrome
22%
Coronavirinae
22%
Coronavirus Infection
22%
Inflammation
11%
Immunotherapy
11%
Clinical Trial
11%
Vaccine Development
11%
Lymphocytopenia
11%
Cytokine Storm
11%
Diseases
11%